Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy

Cancer

Volumn 77, Issue 12, 1996, Pages 2622-2629

  Jacquet, Pierre ^a   Stephens, Arvil D ^a   Averbach, Andrew M ^a   Chang, David ^b   Ettinghausen, Steven E ^a   Dalton, Rory R ^a   Steves, Mark A ^a   Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

^b WESTAT   (United States)

Author keywords

Complications; Hyperthermia; Intraperitoneal chemotherapy; Mitomycin C

Indexed keywords

FLUOROURACIL; MITOMYCIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BLOOD TOXICITY; CARCINOMATOUS PERITONITIS; CLINICAL TRIAL; FEMALE; HUMAN; HYPERTHERMIC THERAPY; INTESTINE FISTULA; INTRAPERITONEAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONEUM LAVAGE; PRIORITY JOURNAL; TEMPERATURE; CARCINOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERITONEUM TUMOR; PEROPERATIVE CARE; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0029665443     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960615)77:12<2622::AID-CNCR28>3.0.CO;2-T     Document Type: Article

References (39)

1. Chu DZJ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989;63:364-7.
2. Speyer JL. The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies. Semin Oncol 1985; 12(Suppl 4):23-8.
3. Sugarbaker PH, Zhu BW, Banez Sese G, Shmookler B. Peritoneal carcinomatosis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. Dis Colon Rectum 1993;36:323-9.
4. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221:124-32.
5. Piver MD, Lele SB, Marchetti DL. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian cancer. J Clin Oncol 1988;6:989-93.
6. Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Hull WE, et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 1990;50:5790-4.
7. Jacquet P, Sugarbaker PH. Abdominal adhesions causing intestinal obstruction following cytoreductive surgery and early postoperative intraperitoneal chemotherapy. Acta Chir Austriaca 1995;27:92-5.
8. Jacquet P, Sugarbaker PH. Influence of wound healing on gastrointestinal cancer recurrence. Wounds 1995;7(2):1-8.
9. Los G, McVie JG. Experimental and clinical status of intraperitoneal chemotherapy. Eur J Cancer 1990;26:755-62.
10. Oleson JR, Calderwood CT, Coughlin CT, Dewhirst MW, Gerweck LE, Gibbs FA, et al. Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol 1988;11:368-80.
11. Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC. Enhancement by hyperthermia of the in vivo cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981;41:1096-9.
12. Wallner KE, Branda M, Li GC. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells. Cancer Res 1987;47:1308-12.
13. Murakami A, Shigemasa K, Maeta M. Thermochemosensitivity: augmentation by hyperthermia of cytotoxicity of anticancer drugs against colorectal cancers, measured by the human tumor clonogenic assay. Oncology 1988;45:236-41.
14. Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Takahashi M, et al. Clinical trial with surgery and intraperitoneal hyperthermic perfusion for peritoneal recurrence of gastrointestinal cancer. Cancer 1989;64:154-60.
15. Gilly FN, Sayag AC, Carry PY, Braillon GG, James IM, Volloch AA, et al. Intraperitoneal chemo-hyperthermia (CHIP): a new therapy in the treatment of the peritoneal seedings. Preliminary report. Int Surg 1991;76:164-7.
16. Fujimoto S, Takahashi M, Endoh F, Sherstha RD, Kokubun M, Takai M, et al. A clinical pilot study combining surgery with intraoperative pelvic hyperthermochemotherapy to prevent the local recurrence of rectal cancer. Ann Surg 1991;13:43-7.
17. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221:29-42.
18. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH, editor. Peritoneal carcinomatosis: diagnosis and treatment. Boston: Kluwer Academic Publishers, 1996:359-73.
19. Miller AB, Hoogstraaten B, Staquet M, Wrinkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
20. Coller JA. Clinical application of anorectal manometry. Gastroenterol Clin North Am 1987;16:17-33.
21. Lepock JR, Frey HE, Kruuv J. Mechanisms of thermal cytotoxicity. Hypertherm Oncol 1992;1:4.
22. Yonemura Y, Ninomya I, Sugiyama K, Fujimura K, Sawa T, Katayama K, et al. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg 1995;19:450-5.
23. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Finals results of a randomized controlled study. Cancer 1994;73:2048-52.
24. Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, et al. Positive results of combined therapy of surgery and Intraperitoneal hyperthermic perfusion for faradvanced gastric cancer. Ann Surg 1990;212:592-6.
25. Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K, et al. Hyperthermochemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991; 15:530-6.
26. Falcone RE, Nappi JF. Chemotherapy and wound healing. Surg Clin North Am 1984;64:779-94.
27. de Waard JW, Whobbes T, Hendriks T. Early postoperative 5-fluorouracil does not affect the healing of experimental intestinal anastomoses. Int J Colored Dis 1993;8:175-8.
28. Hillan K, Nordlinger B, Ballet F, Puts JP, Infante R. The healing of colonic anastomoses after early intraperitoneal chemotherapy: an experimental study in rats. J Surg Res 1988;44:166-71.
29. de Roy van Zuidewijn DBW, Hendriks T, Wobbes T, de Boer HHM. Intraperitoneal cytostatics impair healing of experimental intestinal anastomosis. Br J Cancer 1991;63:937-41.
30. Graf W, Weiber S, Glimelius B, Jiborn H, Pahlman L, Zederfeldt B. Influence of 5-fluorouracil and folonic acid on colonic healing: an experimental study in the rat. Br J Surg 1992;79:825-8.
31. Fumagalli U, Trabucchi E, Soligo M, Rosati R, Rebuffat C, Tonelli C, et al. Effects of intraperitoneal chemotherapy on anastomotic healing in the rat. J Surg Res 1991;50:82-7.
32. Graf W, Westlin JE, Pahlman L, Glimelius B. Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study. Int J Colored Dis 1994;9:35-9.
33. Nordlinger B, Bouteloup PY, Favre JP, Jaek D, Pellisier JP, Grandjean JP, et al. Early postoperative intraperitoneal chemotherapy (IPC) is feasible and well tolerated in colon cancer. A prospective randomized study. J Cancer Res Clin Oncol 1990;116:A686.
34. Reynolds JV, Karpeh MS, Kelsen D, Hans G, Schwartz G, Garcia C, et al. Does the combination of neoadjuvant chemotherapy and postoperative intraperitoneal therapy increase perioperative complications in patients with gastric adenocarcinoma? Gastroenterology 1995;108:A1241.
35. Sugarbaker PH. Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. World J Surg 1995;19:235-40.
36. Gilly FN, Carry PY, Sayag AC, Brachet A, Panteix G, Salle B, et al. Regional chemotherapy (with mitomycin C) and intraoperative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 1994;41:124-9.
37. Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40:256-60.
38. Yamaguchi A, Tsukioka Y, Fushida S, Kurosaka Y, Kanno M, Yonemura Y, et al. Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancers. Dis Colon Rectum 1992;35:964-8.
39. Schneebaum S, Arnold MW, Staubus A, Young DC, Dumond D, Martin EW. Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases. Ann Surg Oncol 1996;3:44-50.